- Improved Oral Health in Adults with X-Linked Hypophosphatemia Treated with Burosumab.J Clin Endocrinol Metab. 2024 Jun 12:dgae398. doi: 10.1210/clinem/dgae398. PMID: 38864457
-
Clinical identification and endodontic management of furcation canals: a case series.Braz Dent J 2023 Jan-Feb. doi: 10.1590/0103-6440202304817.
- Burosumab and Dental Abscesses in Children With X-Linked Hypophosphatemia. JBMR Plus. Jul 2022. doi/10.1002/jbm4.10672
- Prevalence of Enthesopathies in Adults With X-linked Hypophosphatemia: Analysis of Risk Factors. J Clin Endocrinol Metab. 2022 Jan 1;107(1):e224-e235. doi: 10.1210/clinem/dgab580.
- Oral health-related quality of life in patients with X-linked hypophosphatemia: a qualitative exploration. Endocr Connect. 2022. doi: 10.1530/EC-21-0564.
- Oral Ulcers Resolution Using IL12/23 Blockade in an Infant with Leukocyte Adhesion Deficiency Type 1. J Clin Immunol. 2022. doi: 10.1007/s10875-022-01253-1.
- Chronic neutropenia: how best to assess severity and approach management?. Expert Rev Hematol. 2021. doi: 10.1080/17474086.2021.1976634.
- Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth. JCI Insight 2021. doi: 10.1172/jci.insight.141426.
Martin Biosse-Duplan WP3 ASSURER LA TRADUCTION CLINIQUE POUR LE DIAGNOSTIC ET LE TRAITEMENT DES DDS
13/09/2022